Zydus Cadila is a leading Indian pharmaceutical company with a global presence. Established in 1952, the company focuses on developing and manufacturing a wide range of healthcare products, including generic drugs, vaccines, and herbal remedies. They prioritize research and development and have received regulatory approvals from major authorities worldwide. Notably, Zydus Cadila has contributed to the fight against COVID-19 with the development of ZyCoV-D, the world's first plasmid DNA-based vaccine. Committed to sustainability and social responsibility, Zydus Cadila operates in over 50 countries, making a significant impact on global healthcare.